PE20121562A1 - Derivados de 2-oxo-1-pirrolidinila imidazotiadiazol - Google Patents
Derivados de 2-oxo-1-pirrolidinila imidazotiadiazolInfo
- Publication number
- PE20121562A1 PE20121562A1 PE2012000526A PE2012000526A PE20121562A1 PE 20121562 A1 PE20121562 A1 PE 20121562A1 PE 2012000526 A PE2012000526 A PE 2012000526A PE 2012000526 A PE2012000526 A PE 2012000526A PE 20121562 A1 PE20121562 A1 PE 20121562A1
- Authority
- PE
- Peru
- Prior art keywords
- metoximethyl
- ona
- imidazo
- pyrrolidin
- methyl
- Prior art date
Links
- PLRMQFOCKFVASE-UHFFFAOYSA-N O=C(N=C1N=CN=C11)[S+]1N1CCCC1 Chemical class O=C(N=C1N=CN=C11)[S+]1N1CCCC1 PLRMQFOCKFVASE-UHFFFAOYSA-N 0.000 title 1
- -1 2-OXO-1-PYRROLIDINYL Chemical class 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 3
- CPRCXVAIPPLRJV-UHFFFAOYSA-N 1-chloro-1,1-difluoroethane Chemical class [CH2]C(F)(F)Cl CPRCXVAIPPLRJV-UHFFFAOYSA-N 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 230000002920 convulsive effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09173912 | 2009-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20121562A1 true PE20121562A1 (es) | 2012-11-30 |
Family
ID=42034570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2012000526A PE20121562A1 (es) | 2009-10-23 | 2010-10-21 | Derivados de 2-oxo-1-pirrolidinila imidazotiadiazol |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8822508B2 (forum.php) |
| EP (1) | EP2491045B1 (forum.php) |
| JP (1) | JP5808020B2 (forum.php) |
| KR (1) | KR20120102058A (forum.php) |
| CN (1) | CN102574869A (forum.php) |
| AR (1) | AR078722A1 (forum.php) |
| AU (1) | AU2010310100B2 (forum.php) |
| BR (1) | BR112012009310B8 (forum.php) |
| CA (1) | CA2778194C (forum.php) |
| CL (1) | CL2012001031A1 (forum.php) |
| CY (1) | CY1117288T1 (forum.php) |
| DK (1) | DK2491045T3 (forum.php) |
| EA (1) | EA201200616A1 (forum.php) |
| ES (1) | ES2565515T3 (forum.php) |
| HR (1) | HRP20160263T1 (forum.php) |
| HU (1) | HUE028668T2 (forum.php) |
| IL (1) | IL218696A0 (forum.php) |
| IN (1) | IN2012DN02793A (forum.php) |
| MA (1) | MA33679B1 (forum.php) |
| ME (1) | ME02355B (forum.php) |
| MX (1) | MX347070B (forum.php) |
| PE (1) | PE20121562A1 (forum.php) |
| PH (1) | PH12012500570A1 (forum.php) |
| PL (1) | PL2491045T3 (forum.php) |
| RS (1) | RS54595B1 (forum.php) |
| SI (1) | SI2491045T1 (forum.php) |
| SM (1) | SMT201600076B (forum.php) |
| TN (1) | TN2012000147A1 (forum.php) |
| TW (1) | TW201118103A (forum.php) |
| WO (1) | WO2011047860A1 (forum.php) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957218B2 (en) * | 2011-04-18 | 2015-02-17 | Ucb Pharma S.A. | 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives |
| US9581654B2 (en) | 2013-02-12 | 2017-02-28 | Johnson Controls Technology Company | Vehicle battery monitoring system |
| PT3096790T (pt) | 2014-01-21 | 2019-10-15 | Janssen Pharmaceutica Nv | Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso |
| EP3827830A1 (en) | 2014-01-21 | 2021-06-02 | Janssen Pharmaceutica NV | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| CN110869374B (zh) * | 2017-07-10 | 2022-08-30 | Ucb生物制药有限责任公司 | 2-氧代-1,3-噁唑烷基咪唑并噻二唑衍生物 |
| MA49558A (fr) | 2017-07-10 | 2021-05-05 | UCB Biopharma SRL | Dérivativés de 2-oxo-1-imidazolidinyl imidazothiadiazole |
| CN107827870B (zh) * | 2017-10-24 | 2019-11-08 | 江苏仁明生物科技有限公司 | 一种正电子药物[18f]fpmmp及其制备方法与中间体 |
| EA202091403A1 (ru) * | 2017-12-12 | 2020-10-14 | Юсб Байофарма Срл | Производные 2-оксо-1-пирролидинилимидазотиадиазола |
| US11286266B2 (en) | 2018-05-08 | 2022-03-29 | UCB Biopharma SRL | 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives |
| CN113549052B (zh) * | 2021-07-09 | 2022-09-02 | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 4-苯基-1-（吡啶-4-基甲基）吡咯烷-2-酮衍生物及其制备方法和应用 |
| WO2025132331A1 (en) | 2023-12-21 | 2025-06-26 | UCB Biopharma SRL | Compounds for treatment of a hyperkinetic movement disorder |
| CN119606962B (zh) * | 2025-02-17 | 2025-05-02 | 中国人民解放军总医院第三医学中心 | padsevonil在制备治疗TFE3重排性肾细胞癌的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412358D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| ES2323313T3 (es) | 2003-12-02 | 2009-07-13 | Ucb Pharma, S.A. | Derivados de imidazol, procedimientos para prepararlos y sus usos. |
| EP2308867A3 (en) * | 2005-06-01 | 2011-10-19 | UCB Pharma S.A. | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
-
2010
- 2010-10-21 ES ES10781818.9T patent/ES2565515T3/es active Active
- 2010-10-21 EA EA201200616A patent/EA201200616A1/ru unknown
- 2010-10-21 HR HRP20160263TT patent/HRP20160263T1/hr unknown
- 2010-10-21 KR KR1020127013216A patent/KR20120102058A/ko not_active Withdrawn
- 2010-10-21 DK DK10781818.9T patent/DK2491045T3/en active
- 2010-10-21 EP EP10781818.9A patent/EP2491045B1/en active Active
- 2010-10-21 CA CA2778194A patent/CA2778194C/en active Active
- 2010-10-21 SI SI201031137T patent/SI2491045T1/sl unknown
- 2010-10-21 CN CN2010800476319A patent/CN102574869A/zh active Pending
- 2010-10-21 PH PH1/2012/500570A patent/PH12012500570A1/en unknown
- 2010-10-21 IN IN2793DEN2012 patent/IN2012DN02793A/en unknown
- 2010-10-21 US US13/502,546 patent/US8822508B2/en active Active
- 2010-10-21 TW TW099135866A patent/TW201118103A/zh unknown
- 2010-10-21 PL PL10781818T patent/PL2491045T3/pl unknown
- 2010-10-21 JP JP2012534579A patent/JP5808020B2/ja active Active
- 2010-10-21 HU HUE10781818A patent/HUE028668T2/en unknown
- 2010-10-21 MX MX2012003839A patent/MX347070B/es active IP Right Grant
- 2010-10-21 ME MEP-2016-44A patent/ME02355B/me unknown
- 2010-10-21 RS RS20160156A patent/RS54595B1/en unknown
- 2010-10-21 BR BR112012009310A patent/BR112012009310B8/pt not_active IP Right Cessation
- 2010-10-21 AU AU2010310100A patent/AU2010310100B2/en not_active Ceased
- 2010-10-21 WO PCT/EP2010/006434 patent/WO2011047860A1/en active Application Filing
- 2010-10-21 PE PE2012000526A patent/PE20121562A1/es not_active Application Discontinuation
- 2010-10-22 AR ARP100103864A patent/AR078722A1/es unknown
-
2012
- 2012-03-18 IL IL218696A patent/IL218696A0/en unknown
- 2012-03-29 TN TNP2012000147A patent/TN2012000147A1/en unknown
- 2012-04-19 MA MA34783A patent/MA33679B1/fr unknown
- 2012-04-23 CL CL2012001031A patent/CL2012001031A1/es unknown
-
2016
- 2016-03-15 CY CY20161100217T patent/CY1117288T1/el unknown
- 2016-03-16 SM SM201600076T patent/SMT201600076B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20121562A1 (es) | Derivados de 2-oxo-1-pirrolidinila imidazotiadiazol | |
| PE20080359A1 (es) | Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r | |
| EP2190428A4 (en) | HETEROCYCLIC COMPOUNDS AS DIPEPTIDYLPEPTIDASE IV HEMMER FOR TREATMENT OR PREVENTION OF DIABETES | |
| PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
| PE20121640A1 (es) | Derivados de pirazina como inhibidores de bace | |
| CL2008003339A1 (es) | Compuestos derivados de pirimidin-2(1h)-ona, inhibidores de la 11b-hidroxiesteroide deshidrogenasa 1; composicion farmaceutica, util para el tratamiento de enfermedades tales como obesidad, hipertension e hiperlipidemia. | |
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20061106A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
| PE20141004A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
| PE20142019A1 (es) | Nuevos derivados de acidos indaniloxidihidrobenzofuranilaceticos y sus usos como agonistas del receptor gpr40 | |
| MA33450B1 (fr) | Dérivés d'oxazine et leur utilisation en tant qu'inhibiteurs de bace pour le traitement de troubles neurologiques | |
| TW200700415A (en) | New salt and polymorphs of the dpp-iv inhibitor | |
| MA31419B1 (fr) | Derives de pyridine | |
| TN2011000316A1 (fr) | Derives de sulfonamides | |
| PE20152032A1 (es) | Compuestos de 3,4-dihidroisoquinolin-2(1h)-il | |
| MA37379A1 (fr) | Formes polymorphes de l'acide -2-(1-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one | |
| PE20130457A1 (es) | INHIBIDORES DE mTOR CINASA PARA INDICADORES DE ONCOLOGIA Y ENFERMEDADES ASOCIADAS CON LA TRAYECTORIA mTOR/PI3K/AKT | |
| CL2011002604A1 (es) | Compuestos derivados de n-(cianometil)-4-(sulfonil)pirrolidina-2-carboxamida, inhibidores de catepsina s o l; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento o profilaxis de la diabetes, aterosclerosis, aneurismo aortico abdominal, enfermedades arteriales periferica o la nefropatia diabetica. | |
| PE20142294A1 (es) | Compuestos de indol e indazol que activan la ampk | |
| PE20130184A1 (es) | Compuesto heterociclico | |
| PE20191142A1 (es) | 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos | |
| PE20110875A1 (es) | Derivados de isoindol como inhibidores de bace | |
| GB2511685A (en) | Muscarinic m1 receptor agonists | |
| PE20090984A1 (es) | Inhibidores de peptido desformilasa | |
| MA31834B1 (fr) | 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, leur procédé de production et leur utilisation comme anti-inflammatoires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |